Mr. Kirill Dmitriev - Special Representative of the President of Russia for Foreign Economic and Investment Affairs, General Director of the Russian Direct Investment Fund (RDIF) - representing the Russian side exchanged cooperation documents with Mr. Ngo Chi Dung, Chairman and General Director of VNVC Vaccine Company, in the presence of Russian President Putin and General Secretary To Lam - Photo: Hoang Thong Nhat
On May 10, under the witness of Russian President Vladimir Putin and General Secretary To Lam , Vietnam Vaccine Company (VNVC) and the Russian Direct Investment Fund (RDIF) signed a strategic cooperation agreement, aiming to transfer vaccine production technology, with the expectation of soon accessing cancer vaccines.
The signing document was presented in the presence of the two heads of state of Vietnam and Russia, during the event within the framework of the official visit to the Russian Federation by General Secretary To Lam from May 8 to 11, on the occasion of the 80th anniversary of Victory Day in the Great Patriotic War and the 75th anniversary of the establishment of diplomatic relations between Vietnam and Russia.
Deep cooperation in high technology in the field of biomedicine
According to the cooperation agreement, the two sides will discuss to establish a foundation for deep cooperation on high technology in the field of biomedicine, focusing on research, investment, technology transfer and trade of biological drugs and high-tech vaccines. In particular, VNVC's top expectation is to soon bring in a potential cancer treatment vaccine based on modern mRNA technology that Russia announced in December 2024.
In addition to this important cooperation document, VNVC also signed a cooperation agreement with the Gamaleya National Research Center for Epidemiology and Microbiology on scientific research cooperation and biotechnology development. Research topics will be implemented in the near future.
VNVC vaccine and biological product factory in Vietnam has a total investment of about 2,000 billion VND, designed and built with modern world technology, expected to start construction in 2025 - Photo: VNVC
Also within the framework of cooperation announced between the two official representatives in the medical field of the two units in the two countries, VNVC also signed with the Russian pharmaceutical group Binnopharm, one of the largest pharmaceutical manufacturers in Russia.
Immediately after signing, VNVC will begin scientific exchange activities with scientists from many Russian research institutes and high-level hospitals to receive technology transfer for research, testing and production of vaccines using mRNA technology.
In particular, research and development of vaccine production according to the "complete, closed cycle" model in Vietnam, focusing on pharmaceutical products that are Binnopharm's strengths, along with other important Russian pharmaceutical products, with a special focus on the field of high-tech cancer diagnosis and treatment.
Previously, in December 2024, the National Medical Research Center for Radiology under the Russian Ministry of Health announced that the country was researching and developing a potential lung cancer vaccine, produced using advanced mRNA technology.
In December 2024, the National Medical Research Center for Radiology under the Russian Ministry of Health announced that Russia is researching and developing a cancer treatment vaccine using modern mRNA technology - Photo: TASS
The growth of Vietnamese healthcare on the world healthcare map
Mr. Kirill Dmitriev, special representative of the President of Russia for foreign economic and investment affairs, general director of the Russian Direct Investment Fund (RDIF), said: "Russia and Vietnam have many conditions for investment cooperation and technology transfer, especially in the fields of biomedicine and health care.
During the Covid-19 pandemic, Vietnam is one of the countries that has approved the use of Russia's Sputnik V Covid-19 vaccine.
The cooperation framework we announced today will play an important role in enhancing scientific exchange and technology transfer between our two countries to develop pioneering healthcare products."
Inside the factory of Binnopharm, one of Russia's largest pharmaceutical manufacturers - Photo: Binnopharm
Highly appreciating the cooperative relationship with prestigious Russian agencies, Mr. Ngo Chi Dung, Chairman of the Board of Directors and CEO of VNVC Vaccine Company, affirmed that this is an important milestone, opening up opportunities for Vietnam to access and test vaccines using the most advanced mRNA technology that Russia is promoting research and development.
The two sides will discuss to open up opportunities for Vietnam to have early access to Russia's potential mRNA cancer vaccine, not only for clinical trials and product commercialization but also for production at the VNVC Vaccine and Biological Products Factory in Long An.
Investing in developing modern vaccine production capacity in Vietnam
"In the context that Vietnam records hundreds of thousands of new cases and deaths from cancer each year, this important cooperation agreement will open up new opportunities for cancer treatment with the first vaccine in the country, contributing to cost savings and improving the quality of life for people.
This event affirms the strong efforts of Vietnamese healthcare, which VNVC represents, in international cooperation on science and technology and investment in developing modern vaccine production capacity for Vietnam," said Mr. Ngo Chi Dung.
Read moreBack to Topic Page
QUANG DINH
Source: https://tuoitre.vn/vnvc-hop-tac-voi-quy-dau-tu-nga-ve-vac-xin-cong-nghe-moi-20250512081301638.htm
Comment (0)